Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeNon Operating Investment IncomeOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Wages, Salaries and Other
Others
Ratios

Nexalin Technology (NXL) EBT (2021 - 2025)

Nexalin Technology has reported EBT over the past 5 years, most recently at -$2.4 million for Q4 2025.

  • Quarterly results put EBT at -$2.4 million for Q4 2025, up 16.13% from a year ago — trailing twelve months through Dec 2025 was -$8.2 million (down 8.0% YoY), and the annual figure for FY2025 was -$8.2 million, down 8.0%.
  • EBT for Q4 2025 was -$2.4 million at Nexalin Technology, down from -$2.3 million in the prior quarter.
  • Over the last five years, EBT for NXL hit a ceiling of -$303646.0 in Q3 2022 and a floor of -$2.8 million in Q4 2024.
  • Median EBT over the past 5 years was -$1.2 million (2024), compared with a mean of -$1.4 million.
  • Biggest five-year swings in EBT: soared 83.34% in 2022 and later crashed 656.54% in 2023.
  • Nexalin Technology's EBT stood at -$595928.0 in 2021, then fell by 23.02% to -$733113.0 in 2022, then decreased by 6.49% to -$780669.0 in 2023, then plummeted by 262.95% to -$2.8 million in 2024, then grew by 16.13% to -$2.4 million in 2025.
  • The last three reported values for EBT were -$2.4 million (Q4 2025), -$2.3 million (Q3 2025), and -$1.6 million (Q2 2025) per Business Quant data.